Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
DNA nanostructures are exciting new biomedical tools with myriad potential in treatment, diagnosis and disease prevention.
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback